Central Sensitization in Migraine: A Narrative Review

References

• Arendt-Nielsen L, Morlion B, Perrot S, et al. Assessment and manifestation of central sensitisation across different chronic pain conditions. Eur J Pain. 2018;22(2):216–241. doi:10.1002/ejp.1140
   PubMed Web of Science ®Google Scholar
• Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature. 1983;306(5944):686–688. doi:10.1038/306686a0
   PubMed Web of Science ®Google Scholar
• Woolf CJ. Pain amplification- A perspective on the how, why, when, and where of central sensitization. J Appl Biobehav Res. 2018;23(2):e12124. doi:10.1111/jabr.12124
   Web of Science ®Google Scholar
• Suzuki K, Haruyama Y, Kobashi G, et al. Central sensitization in neurological, psychiatric, and pain disorders: a multicenter case-controlled study. Pain Res Manag. 2021;2021:6656917. doi:10.1155/2021/6656917
   PubMed Web of Science ®Google Scholar
• Ashina M, Terwindt GM, Al-Karagholi MA, et al. Migraine: disease characterisation, biomarkers, and precision medicine. Lancet. 2021;397(10283):1496–1504.
   PubMed Web of Science ®Google Scholar
• Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2–S15. doi:10.1016/j.pain.2010.09.030
   PubMed Web of Science ®Google Scholar
• Nijs J, Torres-Cueco R, van Wilgen CP, et al. Applying modern pain neuroscience in clinical practice: criteria for the classification of central sensitization pain. Pain Physician. 2014;17(5):447–457. doi:10.36076/ppj.2014/17/447
   PubMed Web of Science ®Google Scholar
• Scerbo T, Colasurdo J, Dunn S, Unger J, Nijs J, Cook C. Measurement properties of the central sensitization inventory: a systematic review. Pain Pract. 2018;18(4):544–554. doi:10.1111/papr.12636
   PubMed Web of Science ®Google Scholar
• Mayer TG, Neblett R, Cohen H, et al. The development and psychometric validation of the central sensitization inventory. Pain Pract. 2012;12(4):276–285. doi:10.1111/j.1533-2500.2011.00493.x
   PubMed Web of Science ®Google Scholar
• Starkweather AR, Heineman A, Storey S, et al. Methods to measure peripheral and central sensitization using quantitative sensory testing: a focus on individuals with low back pain. Appl Nurs Res. 2016;29:237–241. doi:10.1016/j.apnr.2015.03.013
   PubMed Web of Science ®Google Scholar
• Jakubowski M, Silberstein S, Ashkenazi A, Burstein R. Can allodynic migraine patients be identified interictally using a questionnaire? Neurology. 2005;65(9):1419–1422. doi:10.1212/01.wnl.0000183358.53939.38
   PubMed Web of Science ®Google Scholar
• Bigal ME, Ashina S, Burstein R, et al. Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology. 2008;70(17):1525–1533. doi:10.1212/01.wnl.0000310645.31020.b1
   PubMed Web of Science ®Google Scholar
• Ruscheweyh R, Marziniak M, Stumpenhorst F, Reinholz J, Knecht S. Pain sensitivity can be assessed by self-rating: development and validation of the pain sensitivity questionnaire. Pain. 2009;146(1–2):65–74. doi:10.1016/j.pain.2009.06.020
   PubMed Web of Science ®Google Scholar
• Ruscheweyh R, Verneuer B, Dany K, et al. Validation of the pain sensitivity questionnaire in chronic pain patients. Pain. 2012;153(6):1210–1218. doi:10.1016/j.pain.2012.02.025
   PubMed Web of Science ®Google Scholar
• Adams GR, Gandhi W, Harrison R, van Reekum CM, Gilron I, Salomons TV. Do “central sensitization” questionnaires reflect measures of nociceptive sensitization or psychological constructs? Protocol for a systematic review. Pain Rep. 2021;6(4):e962. doi:10.1097/PR9.0000000000000962
   PubMedGoogle Scholar
• Edwards RR, Quartana PJ, Allen RP, Greenbaum S, Earley CJ, Smith MT. Alterations in pain responses in treated and untreated patients with restless legs syndrome: associations with sleep disruption. Sleep Med. 2011;12(6):603–609. doi:10.1016/j.sleep.2010.09.018
   PubMed Web of Science ®Google Scholar
• Stiasny-Kolster K, Magerl W, Oertel WH, Moller JC, Treede RD. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain. 2004;127(Pt 4):773–782. doi:10.1093/brain/awh079
   PubMed Web of Science ®Google Scholar
• Meeus M, Nijs J. Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol. 2007;26(4):465–473. doi:10.1007/s10067-006-0433-9
   PubMed Web of Science ®Google Scholar
• Bradley LA, McKendree-Smith NL, Alberts KR, Alarcon GS, Mountz JM, Deutsch G. Use of neuroimaging to understand abnormal pain sensitivity in fibromyalgia. Curr Rheumatol Rep. 2000;2(2):141–148. doi:10.1007/s11926-000-0054-2
   PubMedGoogle Scholar
• Vecchiet L, Montanari G, Pizzigallo E, et al. Sensory characterization of somatic parietal tissues in humans with chronic fatigue syndrome. Neurosci Lett. 1996;208(2):117–120. doi:10.1016/0304-3940(96)12559-3
   PubMed Web of Science ®Google Scholar
• Fernandez-de-las-Penas C, Galan-del-Rio F, Fernandez-Carnero J, Pesquera J, Arendt-Nielsen L, Svensson P. Bilateral widespread mechanical pain sensitivity in women with myofascial temporomandibular disorder: evidence of impairment in central nociceptive processing. J Pain. 2009;10(11):1170–1178. doi:10.1016/j.jpain.2009.04.017
   PubMed Web of Science ®Google Scholar
• Jensen R. Mechanisms of spontaneous tension-type headaches: an analysis of tenderness, pain thresholds and EMG. Pain. 1996;64(2):251–256. doi:10.1016/0304-3959(95)00114-X
   PubMed Web of Science ®Google Scholar
• Munakata J, Naliboff B, Harraf F, et al. Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology. 1997;112(1):55–63. doi:10.1016/s0016-5085(97)70219-1
   PubMed Web of Science ®Google Scholar
• Andersson L, Claeson AS, Dantoft TM, Skovbjerg S, Lind N, Nordin S. Chemosensory perception, symptoms and autonomic responses during chemical exposure in multiple chemical sensitivity. Int Arch Occup Environ Health. 2016;89(1):79–88. doi:10.1007/s00420-015-1053-y
   PubMed Web of Science ®Google Scholar
• Alessandrini M, Micarelli A, Chiaravalloti A, et al. Involvement of subcortical brain structures during olfactory stimulation in multiple chemical sensitivity. Brain Topogr. 2016;29(2):243–252. doi:10.1007/s10548-015-0453-3
   PubMed Web of Science ®Google Scholar
• Lee MC, Zambreanu L, Menon DK, Tracey I. Identifying brain activity specifically related to the maintenance and perceptual consequence of central sensitization in humans. J Neurosci. 2008;28(45):11642–11649. doi:10.1523/JNEUROSCI.2638-08.2008
   PubMed Web of Science ®Google Scholar
• Baron R, Baron Y, Disbrow E, Roberts TP. Activation of the somatosensory cortex during Abeta-fiber mediated hyperalgesia. A MSI study. Brain Res. 2000;871(1):75–82. doi:10.1016/s0006-8993(00)02444-6
   PubMed Web of Science ®Google Scholar
• Cagnie B, Coppieters I, Denecker S, Six J, Danneels L, Meeus M. Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI. Semin Arthritis Rheum. 2014;44(1):68–75. doi:10.1016/j.semarthrit.2014.01.001
   PubMed Web of Science ®Google Scholar
• Barnden LR, Crouch B, Kwiatek R, et al. A brain MRI study of chronic fatigue syndrome: evidence of brainstem dysfunction and altered homeostasis. NMR Biomed. 2011;24(10):1302–1312. doi:10.1002/nbm.1692
   PubMed Web of Science ®Google Scholar
• Shan ZY, Kwiatek R, Burnet R, et al. Progressive brain changes in patients with chronic fatigue syndrome: a longitudinal MRI study. J Magn Reson Imaging. 2016;44(5):1301–1311. doi:10.1002/jmri.25283
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Kurata J, Sekiguchi M, et al. Augmented cerebral activation by lumbar mechanical stimulus in chronic low back pain patients: an FMRI study. Spine. 2009;34(22):2431–2436. doi:10.1097/BRS.0b013e3181b1fb76
   PubMedGoogle Scholar
• Ashina M, Katsarava Z, Do TP, et al. Migraine: epidemiology and systems of care. Lancet. 2021;397(10283):1485–1495. doi:10.1016/S0140-6736(20)32160-7
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. doi:10.1177/0333102417738202
   PubMed Web of Science ®Google Scholar
• Dodick DW, Phase-by-Phase A. Review of Migraine Pathophysiology. Headache. 2018;58(Suppl 1):4–16. doi:10.1111/head.13300
   PubMed Web of Science ®Google Scholar
• Schulte LH, May A. The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain. 2016;139(Pt7):1987–1993. doi:10.1093/brain/aww097
   PubMed Web of Science ®Google Scholar
• Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA. 2001;98(8):4687–4692. doi:10.1073/pnas.071582498
   PubMed Web of Science ®Google Scholar
• Iyengar S, Johnson KW, Ossipov MH, Aurora SK. CGRP and the trigeminal system in migraine. Headache. 2019;59(5):659–681. doi:10.1111/head.13529
   PubMed Web of Science ®Google Scholar
• Zhang X, Levy D, Kainz V, Noseda R, Jakubowski M, Burstein R. Activation of central trigeminovascular neurons by cortical spreading depression. Ann Neurol. 2011;69(5):855–865. doi:10.1002/ana.22329
   PubMed Web of Science ®Google Scholar
• Dodick D, Silberstein S. Central sensitization theory of migraine: clinical implications. Headache. 2006;46(Suppl 4):S182–91. doi:10.1111/j.1526-4610.2006.00602.x
   PubMed Web of Science ®Google Scholar
• Zhang L, Lu C, Kang L, et al. Temporal characteristics of astrocytic activation in the TNC in a mice model of pain induced by recurrent dural infusion of inflammatory soup. J Headache Pain. 2022;23(1):8. doi:10.1186/s10194-021-01382-9
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;97(2):553–622. doi:10.1152/physrev.00034.2015
   PubMed Web of Science ®Google Scholar
• Park CG, Chu MK. Interictal plasma glutamate levels are elevated in individuals with episodic and chronic migraine. Sci Rep. 2022;12(1):6921. doi:10.1038/s41598-022-10883-9
   PubMed Web of Science ®Google Scholar
• de la Coba P, Bruehl S, Del paso GAR. Slowly repeated evoked pain (SREP) as a central sensitization marker in episodic migraine patients. Sci Rep. 2021;11(1):4582. doi:10.1038/s41598-021-84157-1
   PubMed Web of Science ®Google Scholar
• Di Antonio S, Castaldo M, Ponzano M, et al. Disability, burden, and symptoms related to sensitization in migraine patients associate with headache frequency. Scand J Pain. 2021;21(4):766–777. doi:10.1515/sjpain-2021-0050
   PubMed Web of Science ®Google Scholar
• Ishii R, Schwedt TJ, Dumkrieger G, et al. Chronic versus episodic migraine: the 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency. Headache. 2021;61(7):992–1003. doi:10.1111/head.14154
   PubMed Web of Science ®Google Scholar
• Becerra L, Veggeberg R, Prescot A, et al. A ‘complex’ of brain metabolites distinguish altered chemistry in the cingulate cortex of episodic migraine patients. Neuroimage Clin. 2016;11:588–594. doi:10.1016/j.nicl.2016.03.020
   PubMed Web of Science ®Google Scholar
• Mungoven TJ, Henderson LA, Meylakh N. Chronic migraine pathophysiology and treatment: a review of current perspectives. Front Pain Res. 2021;2:705276. doi:10.3389/fpain.2021.705276
   Google Scholar
• Kelman L, Tanis D. The relationship between migraine pain and other associated symptoms. Cephalalgia. 2006;26(5):548–553. doi:10.1111/j.1468-2982.2006.01075.x
   PubMed Web of Science ®Google Scholar
• Schwedt TJ, Chiang CC, Chong CD, Dodick DW. Functional MRI of migraine. Lancet Neurol. 2015;14(1):81–91. doi:10.1016/S1474-4422(14)70193-0
   PubMed Web of Science ®Google Scholar
• Stankewitz A, May A. Increased limbic and brainstem activity during migraine attacks following olfactory stimulation. Neurology. 2011;77(5):476–482. doi:10.1212/WNL.0b013e318227e4a8
   PubMed Web of Science ®Google Scholar
• Vincent M, Pedra E, Mourao-Miranda J, Bramati IE, Henrique AR, Moll J. Enhanced interictal responsiveness of the migraineous visual cortex to incongruent bar stimulation: a functional MRI visual activation study. Cephalalgia. 2003;23(9):860–868. doi:10.1046/j.1468-2982.2003.00609.x
   PubMed Web of Science ®Google Scholar
• Suzuki K, Suzuki S, Haruyama Y, et al. Central sensitization in migraine is related to restless legs syndrome. J Neurol. 2021;268(4):1395–1401. doi:10.1007/s00415-020-10295-7
   PubMed Web of Science ®Google Scholar
• Schurks M, Winter A, Berger K, Kurth T. Migraine and restless legs syndrome: a systematic review. Cephalalgia. 2014;34(10):777–794. doi:10.1177/0333102414537725
   PubMed Web of Science ®Google Scholar
• Danno D, Wolf J, Ishizaki K, Kikui S, Hirata K, Takeshima T. Cranial autonomic symptoms in migraine are related to central sensitization: a prospective study of 164 migraine patients at a tertiary headache center. BMC Neurol. 2022;22(1):89. doi:10.1186/s12883-022-02610-8
   PubMed Web of Science ®Google Scholar
• Aaron LA, Buchwald D. Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Best Pract Res Clin Rheumatol. 2003;17(4):563–574. doi:10.1016/s1521-6942(03)00033-0
   PubMed Web of Science ®Google Scholar
• Suzuki K, Okamura M, Haruyama Y, et al. Exploring the contributing factors to multiple chemical sensitivity in patients with migraine. J Occup Health. 2022;64(1):e12328. doi:10.1002/1348-9585.12328
   PubMed Web of Science ®Google Scholar
• Suzuki K, Suzuki S, Shiina T, et al. Investigating the relationships between the burden of multiple sensory hypersensitivity symptoms and headache-related disability in patients with migraine. J Headache Pain. 2021;22(1):77. doi:10.1186/s10194-021-01294-8
   PubMed Web of Science ®Google Scholar
• Lovati C, Mariotti C, Giani L, et al. Central sensitization in photophobic and non-photophobic migraineurs: possible role of retino nuclear way in the central sensitization process. Neurol Sci. 2013;34(Suppl 1):S133–5. doi:10.1007/s10072-013-1369-x
   PubMed Web of Science ®Google Scholar
• Minguez-Olaondo A, Quintas S, Morollon Sanchez-Mateos N, et al. Cutaneous allodynia in migraine: a narrative review. Front Neurol. 2021;12:831035. doi:10.3389/fneur.2021.831035
   PubMed Web of Science ®Google Scholar
• Mathew PG, Cutrer FM, Garza I. A touchy subject: an assessment of cutaneous allodynia in a chronic migraine population. J Pain Res. 2016;9:101–104. doi:10.2147/JPR.S103238
   PubMed Web of Science ®Google Scholar
• Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000;123(Pt 8):1703–1709. doi:10.1093/brain/123.8.1703
   PubMed Web of Science ®Google Scholar
• Maleki N, Szabo E, Becerra L, et al. Ictal and interictal brain activation in episodic migraine: neural basis for extent of allodynia. PLoS One. 2021;16(1):e0244320. doi:10.1371/journal.pone.0244320
   PubMed Web of Science ®Google Scholar
• Schwedt TJ, Larson-Prior L, Coalson RS, et al. Allodynia and descending pain modulation in migraine: a resting state functional connectivity analysis. Pain Med. 2014;15(1):154–165. doi:10.1111/pme.12267
   PubMed Web of Science ®Google Scholar
• Russo A, Silvestro M, Trojsi F, et al. Cognitive networks disarrangement in patients with migraine predicts cutaneous allodynia. Headache. 2020;60(7):1228–1243. doi:10.1111/head.13860
   PubMed Web of Science ®Google Scholar
• Lovati C, Giani L, Castoldi D, et al. Osmophobia in allodynic migraineurs: cause or consequence of central sensitization? Neurol Sci. 2015;36(Suppl 1):145–147. doi:10.1007/s10072-015-2141-1
   PubMed Web of Science ®Google Scholar
• Ashkenazi A, Yang I, Mushtaq A, Oshinsky ML. Is phonophobia associated with cutaneous allodynia in migraine? J Neurol Neurosurg Psychiatry. 2010;81(11):1256–1260. doi:10.1136/jnnp.2009.198481
   PubMed Web of Science ®Google Scholar
• Delussi M, Vecchio E, Libro G, Quitadamo S, de Tommaso M. Failure of preventive treatments in migraine: an observational retrospective study in a tertiary headache center. BMC Neurol. 2020;20(1):256. doi:10.1186/s12883-020-01839-5
   PubMed Web of Science ®Google Scholar
• Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol. 2004;55(1):19–26. doi:10.1002/ana.10786
   PubMed Web of Science ®Google Scholar
• Barbanti P, Aurilia C, Cevoli S, et al. Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: results of the EARLY 2 study. Headache. 2021;61(9):1351–1363. doi:10.1111/head.14194
   PubMed Web of Science ®Google Scholar
• Lipton RB, Burstein R, Buse DC, et al. Efficacy of erenumab in chronic migraine patients with and without ictal allodynia. Cephalalgia. 2021;41(11–12):1152–1160. doi:10.1177/03331024211010305
   PubMed Web of Science ®Google Scholar
• Hawkins JL, Cornelison LE, Blankenship BA, Durham PL. Vagus nerve stimulation inhibits trigeminal nociception in a rodent model of episodic migraine. Pain Rep. 2017;2(6):e628. doi:10.1097/PR9.0000000000000628
   PubMedGoogle Scholar
• Bono F, Salvino D, Mazza MR, et al. The influence of ictal cutaneous allodynia on the response to occipital transcutaneous electrical stimulation in chronic migraine and chronic tension-type headache: a randomized, sham-controlled study. Cephalalgia. 2015;35(5):389–398. doi:10.1177/0333102414544909
   PubMed Web of Science ®Google Scholar
• Jakubowski M, Levy D, Goor-Aryeh I, Collins B, Bajwa Z, Burstein R. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors. Headache. 2005;45(7):850–861. doi:10.1111/j.1526-4610.2005.05153.x
   PubMed Web of Science ®Google Scholar
• Melo-Carrillo A, Noseda R, Nir RR, et al. Selective inhibition of trigeminovascular neurons by fremanezumab: a humanized monoclonal anti-CGRP antibody. J Neurosci. 2017;37(30):7149–7163. doi:10.1523/JNEUROSCI.0576-17.2017
   PubMed Web of Science ®Google Scholar
• Ashina M, Cohen JM, Galic M, et al. Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 months of treatment in the phase 3b FOCUS study. J Headache Pain. 2021;22(1):68. doi:10.1186/s10194-021-01279-7
   PubMed Web of Science ®Google Scholar
• Durham PL, Cady R. Insights into the mechanism of onabotulinumtoxinA in chronic migraine. Headache. 2011;51(10):1573–1577. doi:10.1111/j.1526-4610.2011.02022.x
   PubMed Web of Science ®Google Scholar
• Suzuki K, Suzuki S, Haruyama Y, Kobashi G, Shiina T, Hirata K. Restless legs syndrome is associated with headache-related disabilities in patients with migraine: a prospective 7-year follow-up study. Eur J Neurol. 2019;26(2):238–245. doi:10.1111/ene.13796
   PubMed Web of Science ®Google Scholar